logo

For the Inventor, By the Inventor

Stegen, Germany

Johannes Hartenstein

This inventor holds 41 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Warner-Lambert Company, Godecke Aktiengesellschaft, Goedecke Aktiengesellschaft. Active years: 1977-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johannes Hartenstein. Retrieved from https://idiyas.com/inventor/johannes-hartenstein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 41

% Patents Active = 100.0

Average Co-Inventor Count = 4.6

ph-index = 11

Forward Citations = 561(Granted Patents)


Location History:

  • Wittental, DE (1977 - 1978)
  • Fohrenbuhl, DE (1979)
  • Stegen-Wittental, DE (1978 - 2000)

Company Filing History:

goldMedal20 out of 2,538 
 
Warner-Lambert Company
 patents
silverMedal11 out of 23 
 
Godecke Aktiengesellschaft
 patents
bronzeMedal10 out of 18 
 
Goedecke Aktiengesellschaft
 patents

Years Active: 1977-2000

Loading Chart...
Areas of Expertise:
Indolocarbazole Derivatives
Cyclic Amino Acids
Naphthyridine Compounds
Pharmaceutical Agents
Aporphine Derivatives
Pyrrolocarbazole
Thioxo-Benzopyrano
Carboxylic Acid Derivatives
Analgesics
Benzothiadiazine Oxides
Dibenzoquinolines
Aminosulfonic Acids
41 patents (USPTO):Explore Patents
1. 6103932 - Substituted cyclic amino acids as pharmaceutical agents (2000-08-15),
2. 5945440 - Indolocarbazole imides and the use thereof (1999-08-31),
3. 5883114 - Indolocarbazole imides and the use thereof (1999-03-16),
4. 5750555 - Bis-indolyl maleinimide or indolopyrrolo carbazole containing an amino (1998-05-12),
5. 5516915 - Bis-(1H-indol-3-yl)-maleinimide derivatives, processes for the (1996-05-14),
6. 5489608 - Indolocarbazole derivatives and the use thereof (1996-02-06),
7. 5438050 - Indolocarbazole derivatives, processes for their preparation and (1995-08-01),
8. 5401875 - 2-aminocarboxylic acids and their derivatives, processes for their (1995-03-28),
9. 5380746 - Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the (1995-01-10),
10. 5322844 - Alkoxy-4 (1H)-pyridone derivatives, processes for the preparation (1994-06-21),
11. 5185352 - Alkoxy-4(1H)-pyridone derivatives, processes for the preparation thereof (1993-02-09),
12. 5091567 - Process for the preparation of 1-aminomethyl-1-cyclohexaneacetic acid (1992-02-25),
13. 5043335 - Indolocarbazoles and the use thereof (1991-08-27),
14. 4912107 - Pyrrolocarbazole derivatives, compositions containing them, and methods (1990-03-27),
15. 4762837 - 4-alkoxy-pyrido[2,3-d]pyrimidine derivatives for treatment of myocardiac (1988-08-09),

Title: Innovations and Contributions of Johannes Hartenstein

Introduction: Johannes Hartenstein, based in Stegen-Wittental, Germany, is a prolific inventor with a notable record of 41 patents. His work primarily focuses on pharmaceutical agents, contributing significantly to advancements in medical science.

Latest Patents: Hartenstein's recent patents include groundbreaking innovations such as "Substituted cyclic amino acids as pharmaceutical agents" and "Indolocarbazole imides and the use thereof." The latter patent addresses the preparation of pharmaceutical compositions aimed at treating and preventing a variety of conditions including cancer, viral diseases like HIV infections, cardiovascular diseases, and neurodegenerative disorders such as Alzheimer's disease. These innovations also explore the use of new compounds identified by the general formula (I), playing a crucial role in advancing therapeutic options.

Career Highlights: Throughout his career, Johannes Hartenstein has been affiliated with prominent organizations. He has worked with Warner-Lambert Company and Godecke Aktiengesellschaft, where he leveraged his expertise in pharmaceutical research and development to produce innovative solutions.

Collaborations: Hartenstein's successful endeavors have seen him collaborate with esteemed colleagues, including Gerhard Satzinger and Edgar Fritschi. These collaborations have contributed to the development of various pharmaceutical innovations that address pressing health concerns.

Conclusion: Johannes Hartenstein's contributions to the field of pharmaceuticals reflect his dedication to innovation and his ability to tackle complex medical challenges. With a strong portfolio of patents, his work continues to inspire advancements in treatment options for a multitude of diseases. His legacy as an inventor in the pharmaceutical sector is marked by significant advancements that have the potential to impact global health positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…